SLNO logo

Soleno Therapeutics, Inc. (SLNO) EBIT

annual EBIT:

-$175.62M-$136.63M(-350.44%)
December 31, 2024

Summary

  • As of today (August 21, 2025), SLNO annual earnings before interest & taxes is -$175.62 million, with the most recent change of -$136.63 million (-350.44%) on December 31, 2024.
  • During the last 3 years, SLNO annual EBIT has fallen by -$143.36 million (-444.40%).
  • SLNO annual EBIT is now -20634.24% below its all-time high of -$847.00 thousand, reached on December 31, 2013.

Performance

SLNO EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSLNOincome statement metrics

quarterly EBIT:

-$3.33M+$39.08M(+92.14%)
June 30, 2025

Summary

  • As of today (August 21, 2025), SLNO quarterly earnings before interest & taxes is -$3.33 million, with the most recent change of +$39.08 million (+92.14%) on June 30, 2025.
  • Over the past year, SLNO quarterly EBIT has increased by +$18.52 million (+84.75%).
  • SLNO quarterly EBIT is now -270.11% below its all-time high of $1.96 million, reached on March 31, 2013.

Performance

SLNO quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSLNOincome statement metrics

TTM EBIT:

-$175.06M+$18.52M(+9.57%)
June 30, 2025

Summary

  • As of today (August 21, 2025), SLNO TTM earnings before interest & taxes is -$175.06 million, with the most recent change of +$18.52 million (+9.57%) on June 30, 2025.
  • Over the past year, SLNO TTM EBIT has dropped by -$109.30 million (-166.21%).
  • SLNO TTM EBIT is now -9037.46% below its all-time high of $1.96 million, reached on March 31, 2013.

Performance

SLNO TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSLNOincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

SLNO EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-350.4%+84.8%-166.2%
3 y3 years-444.4%+45.9%-551.8%
5 y5 years-657.1%+60.1%-482.9%

SLNO EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-629.7%at lowat high+95.8%-627.4%+9.6%
5 y5-year-657.1%at lowat high+95.8%-627.4%+9.6%
alltimeall time<-9999.0%at low-270.1%+95.8%-9037.5%+9.6%

SLNO EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
-$3.33M(-92.1%)
-$175.06M(-9.6%)
Mar 2025
-
-$42.41M(-15.1%)
-$193.58M(+12.2%)
Dec 2024
-$175.62M(+350.4%)
-$49.98M(-37.0%)
-$172.57M(+27.1%)
Sep 2024
-
-$79.33M(+263.0%)
-$135.73M(+106.4%)
Jun 2024
-
-$21.85M(+2.1%)
-$65.76M(+25.9%)
Mar 2024
-
-$21.40M(+62.8%)
-$52.22M(+33.9%)
Dec 2023
-$38.99M(+62.0%)
-$13.15M(+40.4%)
-$38.99M(+25.7%)
Sep 2023
-
-$9.36M(+12.6%)
-$31.01M(+11.7%)
Jun 2023
-
-$8.31M(+1.7%)
-$27.75M(+8.4%)
Mar 2023
-
-$8.17M(+58.0%)
-$25.61M(+6.4%)
Dec 2022
-$24.07M(-25.4%)
-$5.17M(-15.3%)
-$24.07M(-4.6%)
Sep 2022
-
-$6.10M(-1.0%)
-$25.23M(-6.1%)
Jun 2022
-
-$6.16M(-7.1%)
-$26.86M(-6.6%)
Mar 2022
-
-$6.63M(+4.8%)
-$28.75M(-10.9%)
Dec 2021
-$32.26M(+1.0%)
-$6.33M(-18.2%)
-$32.26M(-4.4%)
Sep 2021
-
-$7.74M(-3.9%)
-$33.75M(+2.0%)
Jun 2021
-
-$8.05M(-20.6%)
-$33.09M(-0.9%)
Mar 2021
-
-$10.14M(+29.8%)
-$33.39M(+4.5%)
Dec 2020
-$31.95M(+37.7%)
-$7.82M(+10.4%)
-$31.95M(+3.0%)
Sep 2020
-
-$7.08M(-15.2%)
-$31.01M(+3.3%)
Jun 2020
-
-$8.35M(-4.0%)
-$30.03M(+10.7%)
Mar 2020
-
-$8.70M(+26.4%)
-$27.12M(+16.9%)
Dec 2019
-$23.20M
-$6.88M(+12.7%)
-$23.20M(+16.7%)
Sep 2019
-
-$6.11M(+12.2%)
-$19.87M(+14.1%)
Jun 2019
-
-$5.44M(+14.0%)
-$17.42M(+12.7%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$4.77M(+34.2%)
-$15.46M(+12.6%)
Dec 2018
-$13.73M(+6.9%)
-$3.56M(-2.5%)
-$13.73M(-14.5%)
Sep 2018
-
-$3.65M(+4.9%)
-$16.06M(+6.8%)
Jun 2018
-
-$3.48M(+14.2%)
-$15.04M(+3.5%)
Mar 2018
-
-$3.05M(-48.2%)
-$14.53M(+13.0%)
Dec 2017
-$12.85M(+54.4%)
-$5.88M(+123.5%)
-$12.85M(+46.0%)
Sep 2017
-
-$2.63M(-11.4%)
-$8.81M(+8.1%)
Jun 2017
-
-$2.97M(+116.2%)
-$8.14M(+9.0%)
Mar 2017
-
-$1.37M(-25.1%)
-$7.47M(-27.9%)
Dec 2016
-$8.32M(-31.5%)
-$1.83M(-6.9%)
-$10.36M(+35.9%)
Sep 2016
-
-$1.97M(-14.2%)
-$7.62M(-14.8%)
Jun 2016
-
-$2.29M(-46.2%)
-$8.95M(-7.7%)
Mar 2016
-
-$4.26M(-571.9%)
-$9.70M(+23.4%)
Dec 2015
-$12.16M(+33.5%)
$903.30K(-127.4%)
-$7.86M(-46.0%)
Sep 2015
-
-$3.29M(+8.2%)
-$14.56M(+15.7%)
Jun 2015
-
-$3.04M(+25.5%)
-$12.59M(+16.0%)
Mar 2015
-
-$2.43M(-58.1%)
-$10.85M(+22.3%)
Dec 2014
-$9.11M(+975.2%)
-$5.79M(+337.9%)
-$8.87M(+137.1%)
Sep 2014
-
-$1.32M(+1.2%)
-$3.74M(+54.7%)
Jun 2014
-
-$1.31M(+193.0%)
-$2.42M(+4.5%)
Mar 2014
-
-$446.00K(-32.8%)
-$2.31M(-2591.3%)
Dec 2013
-$847.00K(-76.6%)
-$664.00K(-44.8%)
$92.80K(-87.7%)
Jun 2013
-
-$1.20M(-161.4%)
$756.80K(-61.4%)
Mar 2013
-
$1.96M
$1.96M
Dec 2012
-$3.62M
-
-

FAQ

  • What is Soleno Therapeutics, Inc. annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Soleno Therapeutics, Inc.?
  • What is Soleno Therapeutics, Inc. annual EBIT year-on-year change?
  • What is Soleno Therapeutics, Inc. quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Soleno Therapeutics, Inc.?
  • What is Soleno Therapeutics, Inc. quarterly EBIT year-on-year change?
  • What is Soleno Therapeutics, Inc. TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Soleno Therapeutics, Inc.?
  • What is Soleno Therapeutics, Inc. TTM EBIT year-on-year change?

What is Soleno Therapeutics, Inc. annual earnings before interest & taxes?

The current annual EBIT of SLNO is -$175.62M

What is the all time high annual EBIT for Soleno Therapeutics, Inc.?

Soleno Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$847.00K

What is Soleno Therapeutics, Inc. annual EBIT year-on-year change?

Over the past year, SLNO annual earnings before interest & taxes has changed by -$136.63M (-350.44%)

What is Soleno Therapeutics, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of SLNO is -$3.33M

What is the all time high quarterly EBIT for Soleno Therapeutics, Inc.?

Soleno Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $1.96M

What is Soleno Therapeutics, Inc. quarterly EBIT year-on-year change?

Over the past year, SLNO quarterly earnings before interest & taxes has changed by +$18.52M (+84.75%)

What is Soleno Therapeutics, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of SLNO is -$175.06M

What is the all time high TTM EBIT for Soleno Therapeutics, Inc.?

Soleno Therapeutics, Inc. all-time high TTM earnings before interest & taxes is $1.96M

What is Soleno Therapeutics, Inc. TTM EBIT year-on-year change?

Over the past year, SLNO TTM earnings before interest & taxes has changed by -$109.30M (-166.21%)
On this page